MATTI HUDAK: Open Payments
NPI 1376166447 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 9 payments from 6 companies in 2025. Trend: 2023 $79 · 2024 $0 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | 3 | $144 |
| Novo Nordisk Inc | 2 | $139 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $119 |
| Azurity Pharmaceuticals, Inc. | 1 | $27 |
| SANOFI-AVENTIS U.S. LLC | 1 | $24 |
| Medtronic, Inc. | 1 | $20 |
Products named: Yorvipath, Ozempic, NEFFY, TRIPTODUR, TZIELD, MINIMED 780G, Skytrofa, Sogroya.
Industry payments across FL — which companies pay providers there.
